Anne Stehr
YOU?
Author Swipe
View article: Figure S3 from ABO Blood Group IgM Isoagglutinins Interact with Tumor-Associated O-Glycan Structures in Pancreatic Cancer
Figure S3 from ABO Blood Group IgM Isoagglutinins Interact with Tumor-Associated O-Glycan Structures in Pancreatic Cancer Open
Supplement Figures S3 A-D: Quantification of total IgM for blood group O, A, B and AB. A: Total IgM levels from samples of blood group O were analyzed for 19 PDAC patients and 21 healthy controls. B: Total IgM levels from samples of blood …
View article: Figure S1 from ABO Blood Group IgM Isoagglutinins Interact with Tumor-Associated O-Glycan Structures in Pancreatic Cancer
Figure S1 from ABO Blood Group IgM Isoagglutinins Interact with Tumor-Associated O-Glycan Structures in Pancreatic Cancer Open
Supplemental Figure S1: Relative Survival of PDAC patients with different blood groups. Kaplan Meier survival plot shows relative survival of PDAC patients in blood group O (blue), blood group A (green), blood group B (yellow) and blood gr…
View article: Figure S1 from ABO Blood Group IgM Isoagglutinins Interact with Tumor-Associated O-Glycan Structures in Pancreatic Cancer
Figure S1 from ABO Blood Group IgM Isoagglutinins Interact with Tumor-Associated O-Glycan Structures in Pancreatic Cancer Open
Supplemental Figure S1: Relative Survival of PDAC patients with different blood groups. Kaplan Meier survival plot shows relative survival of PDAC patients in blood group O (blue), blood group A (green), blood group B (yellow) and blood gr…
View article: Figure S2 from ABO Blood Group IgM Isoagglutinins Interact with Tumor-Associated O-Glycan Structures in Pancreatic Cancer
Figure S2 from ABO Blood Group IgM Isoagglutinins Interact with Tumor-Associated O-Glycan Structures in Pancreatic Cancer Open
Supplemental Figure S2 A-D: Isoagglutinin titers of blood group O, A and B. Isoagglutinin titers were determined for blood group O, A and B with absolute numbers of PDAC sera or healthy control sera. A: Blood group O PDAC sera showed a med…
View article: Data from ABO Blood Group IgM Isoagglutinins Interact with Tumor-Associated O-Glycan Structures in Pancreatic Cancer
Data from ABO Blood Group IgM Isoagglutinins Interact with Tumor-Associated O-Glycan Structures in Pancreatic Cancer Open
Purpose: The ABO gene locus is associated with the risk of developing pancreatic ductal adenocarcinoma (PDAC) resulting in an increased incidence in individuals with non-O blood groups. Up to 90% of PDAC specimens display alterations in mu…
View article: Figure S3 from ABO Blood Group IgM Isoagglutinins Interact with Tumor-Associated O-Glycan Structures in Pancreatic Cancer
Figure S3 from ABO Blood Group IgM Isoagglutinins Interact with Tumor-Associated O-Glycan Structures in Pancreatic Cancer Open
Supplement Figures S3 A-D: Quantification of total IgM for blood group O, A, B and AB. A: Total IgM levels from samples of blood group O were analyzed for 19 PDAC patients and 21 healthy controls. B: Total IgM levels from samples of blood …
View article: Figure S2 from ABO Blood Group IgM Isoagglutinins Interact with Tumor-Associated O-Glycan Structures in Pancreatic Cancer
Figure S2 from ABO Blood Group IgM Isoagglutinins Interact with Tumor-Associated O-Glycan Structures in Pancreatic Cancer Open
Supplemental Figure S2 A-D: Isoagglutinin titers of blood group O, A and B. Isoagglutinin titers were determined for blood group O, A and B with absolute numbers of PDAC sera or healthy control sera. A: Blood group O PDAC sera showed a med…
View article: Data from ABO Blood Group IgM Isoagglutinins Interact with Tumor-Associated O-Glycan Structures in Pancreatic Cancer
Data from ABO Blood Group IgM Isoagglutinins Interact with Tumor-Associated O-Glycan Structures in Pancreatic Cancer Open
Purpose: The ABO gene locus is associated with the risk of developing pancreatic ductal adenocarcinoma (PDAC) resulting in an increased incidence in individuals with non-O blood groups. Up to 90% of PDAC specimens display alterations in mu…